Accelerating Study Start-up with Connected Study Build
In the current clinical trial landscape, study build and start-up have become increasingly complex. Protocols are more sophisticated, timelines are tighter, and teams must often navigate multiple systems to prepare for execution. When study setup is treated as a series of disconnected activities, timelines stretch and the risk of rework increases. To overcome these hurdles, a connected approach to study build is essential for moving studies forward faster.
Why Traditional Study Build Slows Start-up
Several factors currently drive delays in study start-up:
- Protocol Complexity: Translating sophisticated protocols with numerous endpoints and frequent amendments into operational designs requires intense coordination.
- Sequential Validation: CRFs, edit checks, and workflows often undergo multiple rounds of manual testing and validation in sequence, adding significant time.
- Collaboration Bottlenecks: Dependencies between data management, clinical operations, and review teams can lead to extended review cycles.
- Manual Handoffs: Creating study components separately across different systems increases both effort and operational risk.
The Power of a Connected Approach
The Medidata Data Experience shifts the paradigm by connecting study build, data capture, and downstream workflows on a single platform. Instead of configuring systems in isolation, teams work from shared study components that are applied consistently across EDC and adjacent solutions.
This connected strategy allows teams to:
- Build in Parallel: Core study configurations are established once and applied across EDC, eCOA, and randomization simultaneously.
- Reduce Rework: Early alignment across systems limits the need for late-stage updates and extended re-validation cycles.
- Ensure Data Readiness: Because data is structured and standardized from Day 1, monitoring and analytics can begin much earlier.
AI-Powered Efficiency
Within this connected framework, AI automates the most manual aspects of the build process. By generating key components from structured inputs and reusable libraries, teams can achieve faster, more consistent study readiness. Key AI capabilities include:
- Protocol Auto-extraction: Identifying design elements from complex protocols to reduce manual interpretation errors.
- CRF & Edit Check Auto-creation: Leveraging historical libraries and predefined logic to accelerate form and rule development.
- Synthetic Test Data Generation: Creating study-specific data for UAT and validation to shorten testing cycles.
Case Study: Readiness in Two Weeks
The impact of this connected approach is quantifiable. A top 20 global pharmaceutical company recently partnered with Medidata to standardize its eCOA implementation. By reusing validated instruments and established configurations, they reduced English build timelines from the traditional 8–12 weeks down to just two weeks. This repeatable process was successfully scaled across more than 50 studies.
Conclusion
Accelerating study start-up requires a fundamental change in how trials are designed and built. By grounding the build process in a connected data layer, organizations can eliminate traditional bottlenecks, reduce site burden, and move toward study readiness with greater confidence. In an industry where speed to market is critical, a connected study build is the engine that moves life-saving therapies forward.
Download the ebook to discover how to Accelerate Study Start-up with Connected Study Build
